The Intersection / Microplastics
Two Americas: How Science in Plastics Litigation Shapes Our Future
Learn More
July 2, 2025
Microplastics present a complex public health challenge and significant methodological obstacles—including lack of standardized testing protocols, difficulty establishing causal relationships, and challenges in exposure assessment—currently limit our ability to develop evidence-based policies.
Microplastics
The Truth About Microplastics Litigation in America
A data-driven look at the Intersection of Science, Justice, and Economics
Microplastics, defined as plastic particles smaller than 5 millimeters, have emerged as a pervasive environmental contaminant presenting complex challenges at the intersection of scientific research, environmental justice, and economic considerations. Current evidence suggests these particles may adversely affect human reproductive, digestive, and respiratory health through mechanisms including oxidative stress and inflammation, while creating significant methodological challenges for researchers.
Key Themes At A Glance
- 📈 Litigation Surge: Plastics lawsuits rose dramatically in 2023–2024. False advertising (49%) and state code violations (55%) are the most frequent legal claims.
- 🧪 Science on Trial: Courts are often forced to rule on unsettled scientific issues like microplastics exposure and recyclability—decisions typically outside their expertise.
- ⚖️ Justice System Gaps: A fragmented legal system has produced inconsistent rulings, leaving businesses and consumers with unclear standards.
- 💸 Economic Stakes: 45% of cases seek injunctive relief, potentially disrupting entire markets by mandating sudden product or packaging changes.
- 🧭 Policy Blind Spots: Current litigation is filling a void left by inconsistent regulations and a lack of coordinated scientific guidance.
Why This Matters
- The science is still emerging. Courts are making binding legal decisions on topics where scientific consensus has not yet formed.
- The stakes are high. Companies face multimillion-dollar risks, and misguided decisions could chill innovation or increase costs for everyday consumers.
- The system is out of sync. Legal and regulatory frameworks haven’t caught up to the complexity of environmental science and health research.